Top Stories
Top Stories
Pharmaceuticals

McKesson to pay $37 million to resolve West Virginia opioid lawsuit

Key Points
  • Drug distributor McKesson has agreed to pay $37 million to resolve a lawsuit by the state of West Virginia seeking to hold it responsible for contributing to the opioid epidemic, the state's attorney general said on Thursday.
  • The settlement announced by West Virginia Attorney General Patrick Morrisey resolves one of hundreds of cases McKesson faces by states and local governments alleging it failed to identify suspicious orders by pharmacies of painkillers.
Members of the International Brotherhood of Teamsters hold signs while protesting during the McKesson Corp. annual meeting at the Irving-Las Colinas Chamber of Commerce in Irving, Texas, U.S., on Wednesday, July 26, 2017.
Laura Buckman | Bloomberg | Getty Images

Drug distributor McKesson has agreed to pay $37 million to resolve a lawsuit by the state of West Virginia seeking to hold it responsible for contributing to the opioid epidemic, the state's attorney general said on Thursday.

The settlement announced by West Virginia Attorney General Patrick Morrisey resolves one of hundreds of cases McKesson faces by states and local governments alleging it failed to identify suspicious orders by pharmacies of painkillers.

The settlement was the largest that a distributor has struck with a state in the litigation. West Virginia in 2017 settled similar cases against rival distributors Cardinal Health and AmerisourceBergen for $20 million and $16 million, respectively.

McKesson did not admit wrongdoing as part of the settlement, which resolved a lawsuit Morrisey's office filed in Boone County Circuit Court in 2016.

"McKesson is committed to working with others to end this national crisis ... and is pleased that the settlement provides funding toward initiatives intended to address the opioid epidemic," the company said in a statement.

Opioids, including prescription painkillers, heroin and fentanyl, were involved in a record 47,600 overdose deaths in 2017, according to the U.S. Centers for Disease Control and Prevention.

The epidemic has prompted lawsuits by state and local governments accusing drug manufacturers like Purdue Pharma of deceptively marketing opioids and distributors like McKesson of failing to detect the diversion of the drugs for illicit purposes.

McKesson in January 2017 agreed to pay $150 million to resolve a federal investigation by the U.S. Drug Enforcement Administration into whether it failed to report suspicious orders of addictive painkillers.

Next Article
Key Points
  • The lawsuit accuses six opioid manufacturers; the Sackler family, which owns Purdue Pharma, and four prescription drug distributors of using false and deceptive marketing practices and unlawfully diverting drugs.
  • The news comes after Purdue and the Sackler family agreed to pay $270 million to the state of Oklahoma after it alleged the drugmaker ruthlessly marketed and misled the public about OxyContin.